nView medical Inc. news
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI
nView medical Inc. (nView) announces the 510(k) clearance of the nView s1 with navigation option by the U.S. Food and Drug Administration (FDA).
nView’s mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 is an imaging system that integrate
The nView s1, nView medical’s breakthrough imaging system reached its 50th surgery. Twelve surgeons across three leading pediatric hospitals have used nView’s insta-3D™ technology on procedures ranging from spinal deformity corrections, to discectomies, periacetabular osteotomies and extremity procedures.
nView medical CEO, Cristian Atria, commented:
“To celebrate the 50th surgery milestone we gave the
Children’s National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D™ imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.
nView medical, a medical imaging company with breakthrough image creation technology, is preparing to pilot its first surgical scanner: the nView s1. This week HealthTech Arkansas announced that nView was selected out of a pool of hundreds of applicants to participate in its Accelerator Program, which guarantees pilots within its network of 11 healthcare providers: Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent,